Trusted Frontline Respiratory Support

High flow nasal cannula is an internationally recommended respiratory tool for COVID-19 patients, with recommendations and guidance from healthcare organizations around the world, including:

  • World Health Organization
  • Centers for Disease Control
  • Society for Critical Care Management
  • American College of Emergency Physicians
  • Associazione Italiana Pneumologi Ospedalieri
  • Chinese Thoracic Society
Precision Flow System

Fast Disinfection and Workflow Streamlining

  • Start delivering heated, humidified therapy in minutes.
  • The single use disposable patient circuits can be used up to 30 days, then discarded.
  • The Precision Flow System can be disinfected in less than 10 minutes.
  • Nurse call and EMR integration, as well as a large, easily read LED display allow hospitals options in bedside monitoring.

Want to learn more about Vapotherm high velocity therapy?

Nasal Cavity Flush

More than High Flow Nasal Cannula

More than twenty years ago, Vapotherm invented high flow nasal cannula. Today, Vapotherm high velocity therapy is an advanced form of high flow nasal cannula, capable of providing ventilatory support clinically proven non-inferior to NiPPV – without the need for a tight-fitting respiratory mask.

One device can allow hospitals readiness for a broad range of patient acuity, from supporting the oxygenation and humidification needs of COVID-19 patients, to hypercapnic COPD patients. [1]

Best Practices for Vapotherm High Velocity Therapy for COVID-19 Patients

With the application of a simple surgical mask, particulate spread is similar to that of normal patient breathing. After applying the cannula to the patient, fit a surgical mask, then initiate therapy.

On-demand Webinar: COVID-19: Best Practices with High Velocity Therapy

Presented By: John Walsh, CRT

  • Understand transmission risk when placing COVID-19 patients on high velocity therapy
  • Identify precautions that can be taken
  • Understand high velocity therapy mechanism of action for considerations of patient comorbidities
  • Identify role of high velocity therapy during post-extubation
  • Discuss considerations for conservation of oxygen

This course is AARC accredited for 1 CEU under the Clinical Practice (CLP) category.

COVID-19 Clinical Resources

Looking for more clinical information? Our COVID-19 Resource Center is regularly updated.

SOURCES: [1] Doshi, Pratik et al. High-Velocity Nasal Insufflation in the Treatment of Respiratory Failure: A Randomized Clinical Trial. Annals of Emergency Medicine, 2018. Published online ahead of print.